1. Home
  2. PRPL vs THAR Comparison

PRPL vs THAR Comparison

Compare PRPL & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPL
  • THAR
  • Stock Information
  • Founded
  • PRPL 2010
  • THAR 2017
  • Country
  • PRPL United States
  • THAR United States
  • Employees
  • PRPL N/A
  • THAR 3
  • Industry
  • PRPL Home Furnishings
  • THAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPL Consumer Discretionary
  • THAR Health Care
  • Exchange
  • PRPL Nasdaq
  • THAR Nasdaq
  • Market Cap
  • PRPL 89.8M
  • THAR 101.7M
  • IPO Year
  • PRPL N/A
  • THAR 2022
  • Fundamental
  • Price
  • PRPL $0.73
  • THAR $2.89
  • Analyst Decision
  • PRPL Hold
  • THAR Strong Buy
  • Analyst Count
  • PRPL 1
  • THAR 1
  • Target Price
  • PRPL $1.00
  • THAR $17.00
  • AVG Volume (30 Days)
  • PRPL 639.4K
  • THAR 3.4M
  • Earning Date
  • PRPL 11-04-2025
  • THAR 11-07-2025
  • Dividend Yield
  • PRPL N/A
  • THAR N/A
  • EPS Growth
  • PRPL N/A
  • THAR N/A
  • EPS
  • PRPL N/A
  • THAR N/A
  • Revenue
  • PRPL $457,012,000.00
  • THAR N/A
  • Revenue This Year
  • PRPL N/A
  • THAR N/A
  • Revenue Next Year
  • PRPL $11.87
  • THAR N/A
  • P/E Ratio
  • PRPL N/A
  • THAR N/A
  • Revenue Growth
  • PRPL N/A
  • THAR N/A
  • 52 Week Low
  • PRPL $0.56
  • THAR $0.95
  • 52 Week High
  • PRPL $1.29
  • THAR $9.08
  • Technical
  • Relative Strength Index (RSI)
  • PRPL 41.26
  • THAR 43.65
  • Support Level
  • PRPL $0.69
  • THAR $2.82
  • Resistance Level
  • PRPL $0.84
  • THAR $5.27
  • Average True Range (ATR)
  • PRPL 0.07
  • THAR 0.75
  • MACD
  • PRPL -0.00
  • THAR -0.05
  • Stochastic Oscillator
  • PRPL 31.96
  • THAR 1.84

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: